Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-021099
Filing Date
2014-11-19
Accepted
2014-11-19 13:29:54
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro20140930_10q.htm 10-Q 826793
2 EXHIBIT 31.1 ex31-1.htm EX-31 16183
3 EXHIBIT 31.2 ex31-2.htm EX-31 16148
4 EXHIBIT 32.1 ex32-1.htm EX-32 6077
5 EXHIBIT 32.2 ex32-2.htm EX-32 5687
  Complete submission text file 0001437749-14-021099.txt   5985818

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ahro-20140930.xml EX-101.INS 775092
7 EXHIBIT 101.SCH ahro-20140930.xsd EX-101.SCH 56908
8 EXHIBIT 101.CAL ahro-20140930_cal.xml EX-101.CAL 21892
9 EXHIBIT 101.DEF ahro-20140930_def.xml EX-101.DEF 304952
10 EXHIBIT 101.LAB ahro-20140930_lab.xml EX-101.LAB 374896
11 EXHIBIT 101.PRE ahro-20140930_pre.xml EX-101.PRE 297772
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 141234463
SIC: 2834 Pharmaceutical Preparations